TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment
Relapse in multiple myeloma (MM) decreases therapy efficiency through unclear mechanisms of chemoresistance. Since our group previously demonstrated that heme oxygenase-1 (HO-1) and Toll-like receptor 4 (TLR4) are two signaling pathways protecting MM cells from the proteasome inhibitor bortezomib (B...
Saved in:
Main Authors: | Grazia Scandura (Author), Cesarina Giallongo (Author), Fabrizio Puglisi (Author), Alessandra Romano (Author), Nunziatina Laura Parrinello (Author), Tatiana Zuppelli (Author), Lucia Longhitano (Author), Sebastiano Giallongo (Author), Michelino Di Rosa (Author), Giuseppe Musumeci (Author), Roberto Motterlini (Author), Roberta Foresti (Author), Giuseppe Alberto Palumbo (Author), Giovanni Li Volti (Author), Francesco Di Raimondo (Author), Daniele Tibullo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells
by: Tibullo eDaniele, et al.
Published: (2015) -
Correction: Carota et al. Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models. <i>Antioxidants</i> 2022, <i>11</i>, 1596
by: Giuseppe Carota, et al.
Published: (2023) -
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models
by: Giuseppe Carota, et al.
Published: (2022) -
Heme Oxygenase-1 Overexpression Promotes Uveal Melanoma Progression and Is Associated with Poor Clinical Outcomes
by: Lucia Longhitano, et al.
Published: (2022) -
Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia
by: Alessandra Romano, et al.
Published: (2017)